Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-120080

Chief Dev. & Ops. Officer bought 300 shares at an average $7.15 ($2,145)

From the SEC's structured data for this filing

Trades in this filing

Shemesh Shay · Chief Dev. & Ops. Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-11-16 Purchase : show line 1 in the form +150 $7.10 $1,065 1,245,215 D
2022-11-17 Purchase : show line 2 in the form +150 $7.20 $1,080 1,245,365 D
Open-market purchases · 300 sh · avg $7.15 · $2,145
Loading xslF345X03/tm2230911-1_4seq1.xml…